Zinc-metalloproteases are a large and functionally diverse family of proteolytic enzymes requiring zinc (zinc (Zn)²⁺) in the active site for catalytic activity. They cleave peptide bonds in proteins, causing tissue destruction, immune evasion, and bacterial dissemination. Major families include:

  • Matrix metalloproteinases (MMPs)—host enzymes; MMP-2, MMP-9 degrade collagen and basement membrane
  • Bacterial metalloproteases—virulence factors; e.g., BFT toxin from B. fragilis, P. aeruginosa elastase, Vibrio metalloproteases
  • Thermolysin-like proteases—found in Gram-positive and Gram-negative bacteria

In the microbiome context, bacterial zinc-metalloproteases are critical virulence factors enabling. Epithelial barrier penetration. Immune cell lysis.

Functional shielding in biofilms.

Persistence in chronic infections.

Contents1. Mechanism2. Role in Disease3. Metal Connections4. Connections

Mechanism#

Zinc catalysis in the active site:

Zinc metalloproteases have a catalytic zinc atom coordinated by. Two histidines and one glutamate (the "HExxH" motif, conserved across metalloproteases). Water molecule as the fourth ligand.

The mechanism. Substrate peptide enters the active site. zinc (Zn)²⁺ activates the water molecule to act as a nucleophile.

Water attacks the peptide carbonyl carbon (C=O of the scissile bond).

Peptide bond is hydrolyzed → two fragments released.

Zinc requirement. Unlike many enzymes, zinc-metalloproteases have very tight zinc²⁺ binding (Kd ~10⁻¹⁰ M). Removing or depleting zinc → loss of catalytic activity.

The apoprotein (without zinc) is completely inactive and often unstable.

Notable bacterial zinc-metalloproteases:

BFT toxin (B. fragilis fragilysin). Zinc-dependent serine protease (unusual: serine = nucleophile, but zinc still required for activity). Cleaves E-cadherin → disrupts epithelial tight junctions.

Enables B. fragilis invasion and immune evasion.

Expressed primarily by pathogenic (enterotoxigenic) strains of B. fragilis.

Pseudomonas aeruginosa elastase. Thermolysin-like metalloprotease. Degrades elastin, collagen, immunoglobulins, complement proteins.

Enables P. aeruginosa lung invasion; especially virulent in cystic fibrosis.

Role in Disease#

Diseases featuring bacterial zinc-metalloproteases. Endometriosis: B. fragilis BFT toxin contributes to peritoneal lesion formation and immune dysfunction. Crohn's Disease: BFT-producing B. fragilis strains are enriched; toxin drives barrier disruption and chronic intestinal Metal-Driven Inflammation. Cystic fibrosis pulmonary infection: P. aeruginosa elastase degrades lung elastin and immune proteins; drives progressive lung destruction.

Colorectal Cancer: BFT-producing B. fragilis is associated with dysplasia and tumor progression. Wound infections: Vibrio and Aeromonas metalloproteases in marine/aquatic wound contamination cause rapid tissue necrosis.

Host metalloprotease elevation. In dysbiotic or infected tissues, the host upregulates MMP-2 and MMP-9 as part of the innate immune response. However, excessive MMP activity (driven by sustained bacterial stimulation) causes matrix degradation and barrier failure.

This creates a feed-forward loop: barrier breach → more bacterial invasion → more MMP induction → further barrier damage.

Metal Connections#

Zinc-metalloproteases are a paradigm for Primitive 4: Metal Dependencies as Achilles' Heels:

Zinc starvation as inhibition strategy. High Zinc availability → high BFT expression and activity → tissue destruction. Zinc sequestration (via Lactoferrin, Calprotectin (S100A8/A9)) → low bioavailable Zinc → reduced metalloprotease activity → reduced epithelial damage.

Nutritional immunity against metalloproteases. Host produces Calprotectin (S100A8/A9) (S100A8/A9 dimer)—binds zinc (Zn)²⁺ and manganese (Mn)²⁺, sequestering them in inflamed tissues. Lactoferrin also chelates Zinc (less potent than for Iron, but still relevant). High Calprotectin (S100A8/A9) (seen in inflammatory bowel disease, cancer) may partially limit bacterial metalloprotease activity.

Zinc-iron cross-talk. BFT-producing B. fragilis is also iron-dependent (for other virulence factors). Dual Zinc and Iron depletion is more effective than single-metal targeting.

In dysbiotic states with both metals elevated, both virulence pathways are maximized.

Zinc and immune function. Host Zinc-dependent enzymes (e.g., zinc-finger transcription factors, thymulin) are required for Th1 differentiation and neutrophil recruitment. Zinc deficiency → Th2 shift → reduced IFN-γ → reduced immune pressure on BFT-producing B. fragilis.

This creates a vicious cycle: DysbiosisZinc sequestration (nutritional immunity) → Zinc deficiency → impaired Th1 → pathobiont escape.

Connections#

Related enzymes. Matrix metalloproteinases (MMPs)—host enzymes; elevated in inflammatory disease; can work synergistically with bacterial metalloproteases.—another protease family; overlaps with metalloproteases in substrate specificity.—specific to B. fragilis; major driver of Endometriosis and inflammatory bowel disease.

Related organisms. B. fragilis—primary pathobiont producing BFT toxin. P. aeruginosa—opportunistic pathogen with elastase and other metalloproteases. and Aeromonas—aquatic pathogens with tissue-destructive metalloproteases.

Related concepts. Nutritional Immunity (Metal Sequestration)Zinc sequestration as a defense against metalloproteases. barrier-disruption—metalloproteases degrade tight-junction proteins and extracellular matrix. Biofilm—zinc-metalloproteases enable matrix remodeling and biofilm architectural changes.

metal-cofactor-dependency—general principle; zinc-metalloproteases are a key example.

Related metals and proteins. Zinc—the essential cofactor; zinc depletion is a therapeutic strategy. Calprotectin (S100A8/A9)—sequesters zinc; elevated in inflammatory disease. Lactoferrin—also chelates zinc (less potently than iron).

Iron—often co-depleted with zinc for synergistic effect.

Disease pages. Endometriosis, Crohn's Disease, Colorectal Cancer—conditions where BFT-producing B. fragilis zinc-metalloproteases drive pathology.

Generated evidence record

References 7

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    Golden, M., et al. (2024). Golden et al. 2024 — Metal Chelation as Antibacterial Strategy Against Pseudomonas and Acinetobacter. RSC Chemical Biology.

  2. 2

    Asangba AE, Chen J, Goergen KM et al. (2023). Asangba 2023 — Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. Scientific Reports.

  3. 3

    Paul Metz, Martijn J. H. Tjan, Shaoguang Wu et al. (2019). Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin. Frontiers in Cellular and Infection Microbiology.

  4. 4

    Karen Pendergrass (2025). Pendergrass 2025 — From Dysbiosis to Dyshomeostasis: Why Parkinson's Requires a Metallomic–Microbiome Lens. Zenodo Preprint.

  5. 5

    Taylor-Harding B, Agadjanian H, Nassanian H et al. (2012). Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment. British Journal of Cancer.

  6. 6

    Adi Fish-Williamson, Jennifer Hahn-Holbrook (2023). Fish-Williamson & Hahn-Holbrook 2023 — Nutritional Factors and PPD Cross-National Meta-Analysis. Frontiers in Psychiatry.

  7. 7

    Wilkinson HN, Guinn BA, Hardman MJ (2021). Combined Metallomics/Transcriptomics Profiling Reveals a Major Role for Metals in Wound Repair. Frontiers in Cell and Developmental Biology.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

9 events
  1. published revision

    Backfill inflammation concept links

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  2. published revision

    Complete corpus-wide Dysbiosis linking

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  3. published revision

    Complete Tight junctions contextual coverage

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  4. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +40 −35

    Inspect exact Git diff ↗
  5. published revision

    nightly maintenance: 94 stub demotions, 181 source_count fixes, 22 auto-discovered stubs, 5 adversarial audits, 3 boundary fixes, 3 evidence-level corrections

    WikiBiome Deploy Bot · +3 −0

    Inspect exact Git diff ↗
  6. published revision

    pre-overnight checkpoint 2026-04-18

    WikiBiome Deploy Bot · +4 −2

    Inspect exact Git diff ↗
  7. published revision

    WikiBiome update — 2026-04-15 17:23

    WikiBiome Deploy Bot · +3 −3

    Inspect exact Git diff ↗
  8. published revision

    WikiBiome update — integrity fixes, metallomic diet pages, cross-condition analyses

    WikiBiome Deploy Bot · +25 −23

    Inspect exact Git diff ↗
  9. published revision

    WikiBiome update — 2026-04-10 17:16

    WikiBiome Deploy Bot · +120 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

7 references · 12 backlinks · 5 indexed topics